Experimental study on percutaneous selective isolated hepatic perfusion chemotherapy

Jin-song HE,Cheng-you WANG,Xian-ming WANG,Liang-feng GUO,Hao-hui LIANG,Yong-qiang ZHAN,Ru-ming ZHOU,Shui-bo QIU,Wen-jing QIAN,Ji-Sheng CHEN
DOI: https://doi.org/10.3969/j.issn.1005-6947.2005.07.008
2005-01-01
Abstract:ObjectiveTo investigate the feasibility and isolation efficiency of percutaneous selective isolated hepatic perfusion chemotherapy(PSIHP). MethodsSix pigs underwent the procedure of routine transhepatic arterial infusion(HAI) and 6 underwent PSIHP.5-FU was used in this study. The drug(5-FU) (concentration) of blood from hepatic and systemic veins of both groups was observed. Liver tissue was (investigated) for pathologic changes. ResultsThe peak level of 5-FU concentration in blood from right (hepatic) vein and systemic vein in HAI group was(4082.530415.213)mg/L and (1682.230216.834)mg/L respectively.In PSIHP group, the peak level(5-FU) was(5321.711517.318)mg/L and(510.83452.518)mg/L, respectively.There was a statistically significant difference between HAI group an PSIHP group(P0.01). The level of 5-FU concentration in blood from right hepatic vein of PSIHP group(postfiltration) was(1192.063114.864)mg/L and the filtration rate of charcoal (hemoperfusion) was(77.60.9%). The damage of perfused area of liver tissue was more serious in PSIHP group compared with HAI group. ConclusionsPSIHP is a simple and feasible method for isolated hepatic perfusion. Compared with HAI, PSIHP can increase the concentration level of chemotherapeutic agents in (regional) liver, and can even more markedly decrease the drug concentration in systemic circulation and (decrease) toxic side effcts.
What problem does this paper attempt to address?